Yokohama, Japan

Mizuyo Ida

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2012-2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mizuyo Ida: Innovator in Metallo-β-lactamase Inhibitors

Introduction

Mizuyo Ida is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of metallo-β-lactamase inhibitors. With a total of 2 patents to his name, his work is crucial in combating antibiotic resistance.

Latest Patents

Mizuyo Ida's latest patents focus on metallo-β-lactamase inhibitors. These innovative compounds act as medicaments that inhibit the inactivation of β-lactam antibiotics, thereby recovering their antibacterial activities. The maleic acid derivatives he has developed, characterized by a specific general formula, demonstrate metallo-β-lactamase inhibiting activities. By combining these compounds with β-lactam antibiotics, it is possible to restore the antibacterial efficacy against bacteria that produce metallo-β-lactamase.

Career Highlights

Mizuyo Ida is currently employed at Meiji Seika Kaisha, Ltd., where he continues to advance his research in pharmaceutical sciences. His work has garnered attention for its potential impact on public health, particularly in the fight against antibiotic-resistant infections.

Collaborations

Mizuyo has collaborated with notable colleagues, including Ken Chikauchi and Takao Abe. Their combined expertise has contributed to the successful development of innovative solutions in the field of antibiotic resistance.

Conclusion

Mizuyo Ida's contributions to the development of metallo-β-lactamase inhibitors represent a significant advancement in medicinal chemistry. His work not only highlights the importance of innovation in combating antibiotic resistance but also showcases the collaborative efforts within the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…